Chemical Structure : GSK256066
CAS No.: 801312-28-7
货号: PC-61617Not For Human Use, Lab Use Only.
GSK256066 is a highly potent, selective PDE4B inhibitor with pIC50 of 11.1, apparent IC50 of 3.2 pM, inhibits PDE4 isoforms A-D with equal affinity.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥780 | In stock | |
10 mg | ¥1180 | In stock | |
25 mg | ¥2180 | In stock | |
50 mg | ¥3580 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
GSK256066 is a highly potent, selective PDE4B inhibitor with pIC50 of 11.1, apparent IC50 of 3.2 pM, inhibits PDE4 isoforms A-D with equal affinity.
GSK256066 displays >1,000-fold selectivity over PDE1, 2, 3, 5, 6, and 7.
GSK256066 inhibits LPS induced production of TNF-alpha from isolated human peripheral blood mononuclear cells with pIC50 of 11.1.
GSK256066 inhibits LPS-induced pulmonary neutrophilia with ED50 of 1.1 ug/kg (aqueous suspension) and 2.9 ug/kg (dry powder formulation) in rats.
GSK256066 shows exceptional potency in vitro and in vivo for treatment for COPD and asthma.
分子量 | 518.588 | |
分子式 | C27H26N4O5S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
6-[[3-[(Dimethylamino)carbonyl]phenyl]sulfonyl]-4-[(3-methoxyphenyl)amino]-8-methyl-3-quinolinecarboxamide |
1. Woodrow MD, et al. Bioorg Med Chem Lett. 2009 Sep 1;19(17):5261-5.
2. Tralau-Stewart CJ, et al. J Pharmacol Exp Ther. 2011 Apr;337(1):145-54.
3. Singh D, et al. Respir Res. 2010 Mar 1;11:26.
4. Nials AT,et al. J Pharmacol Exp Ther. 2011 Apr;337(1):137-44.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright